Document Detail


Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: A brief review.
MedLine Citation:
PMID:  21185078     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Iron overload is a frequent consequence in transfusion-dependent myelodysplastic syndromes (MDSs), which often requires iron chelation therapy (ICT). Interestingly, ICT may sometimes induce a hematologic improvement that leads to significant reduction or complete interruption of blood transfusions. This phenomenon has been recently described in MDS treated with the new oral chelator deferasirox. Here we briefly review the literature about this phenomenon and discuss the possible biological mechanisms underlying hematologic effects of deferasirox in MDS, starting from a new paradigmatic case in whom both hemoglobin level and platelet count improved, inducing transfusion-independence, soon after starting the treatment with deferasirox.
Authors:
Roberto Guariglia; Maria Carmen Martorelli; Oreste Villani; Giuseppe Pietrantuono; Giovanna Mansueto; Fiorella D'Auria; Vitina Grieco; Gabriella Bianchino; Rosa Lerose; Giovanni Battista Bochicchio; Pellegrino Musto
Related Documents :
8257068 - Hyperthyroidism and down syndrome.
19014638 - New onset neuromyelitis optica in a young nigerian woman with possible antiphospholipid...
21543008 - A case of aggravation of hemolytic anemia, elevated liver enzymes and low platelet coun...
11075618 - Neurological involvement in antiphospholipid antibodies syndrome (aps).
6103678 - Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrim...
22514688 - Optical coherence tomography in parkinsonian syndromes.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2010-12-22
Journal Detail:
Title:  Leukemia research     Volume:  -     ISSN:  1873-5835     ISO Abbreviation:  -     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7706787     Medline TA:  Leuk Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2010 Elsevier Ltd. All rights reserved.
Affiliation:
Department of Onco-Hematology, Centro di Riferimento Oncologico della Basilicata, IRCCS, Via San Pio 1, 85028 Rionero in Vulture (PZ), Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment...
Next Document:  Effects of dissolved organic matter and reduced sulphur on copper bioavailability in coastal marine ...